Prashant S Giri, Shivani Patel, Foram Thakor, Mitesh Dwivedi
{"title":"白癜风患者IFN-γ、TNF-α和颗粒酶B水平变化的meta分析。","authors":"Prashant S Giri, Shivani Patel, Foram Thakor, Mitesh Dwivedi","doi":"10.1080/1744666X.2025.2510491","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vitiligo is a chronic autoimmune skin depigmenting condition. IFN-γ, TNF-α and granzyme B play key roles in vitiligo pathogenesis, some findings suggest their roles may be contradictory.</p><p><strong>Objective: </strong>We aimed to assess IFN-γ, TNF-α and granzyme B levels in blood and skin of vitiligo patients using a meta-analysis approach. Additionally, we evaluated their association with disease activity.</p><p><strong>Methods: </strong>A Meta-analysis was conducted using Review Manager 5.4 software. A total of 55 studies including 3,023 vitiligo patients and 2,534 controls were included in the study.</p><p><strong>Results: </strong>Pooled results from our meta-analysis indicated significantly elevated IFN-γ protein and transcript levels in blood and skin of vitiligo patients (<i>p</i> < 0.05). TNF-α protein levels were also significantly increased in blood and skin of vitiligo patients (<i>p</i> < 0.05). IFN-γ and TNF-α levels were significantly higher in the lesional skin as compared to non-lesional skin (<i>p</i> < 0.05). Furthermore, elevated levels of IFN-γ and TNF-α were observed in patients with active vitiligo (<i>p</i> < 0.05). Additionally, our study suggested a significant increase in granzyme B levels in vitiligo patients (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>Overall, the meta-analysis suggests that IFN-γ, TNF-α and granzyme B play a crucial role in vitiligo pathogenesis and progression and may serve as potential therapeutic targets for managing the disease. The PROSPERO registration no. for meta-analysis is CRD42024620274.</p>","PeriodicalId":12175,"journal":{"name":"Expert Review of Clinical Immunology","volume":" ","pages":"1-14"},"PeriodicalIF":3.9000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Meta-analysis for alterations of IFN-γ, TNF-α and granzyme B levels in vitiligo patients.\",\"authors\":\"Prashant S Giri, Shivani Patel, Foram Thakor, Mitesh Dwivedi\",\"doi\":\"10.1080/1744666X.2025.2510491\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Vitiligo is a chronic autoimmune skin depigmenting condition. IFN-γ, TNF-α and granzyme B play key roles in vitiligo pathogenesis, some findings suggest their roles may be contradictory.</p><p><strong>Objective: </strong>We aimed to assess IFN-γ, TNF-α and granzyme B levels in blood and skin of vitiligo patients using a meta-analysis approach. Additionally, we evaluated their association with disease activity.</p><p><strong>Methods: </strong>A Meta-analysis was conducted using Review Manager 5.4 software. A total of 55 studies including 3,023 vitiligo patients and 2,534 controls were included in the study.</p><p><strong>Results: </strong>Pooled results from our meta-analysis indicated significantly elevated IFN-γ protein and transcript levels in blood and skin of vitiligo patients (<i>p</i> < 0.05). TNF-α protein levels were also significantly increased in blood and skin of vitiligo patients (<i>p</i> < 0.05). IFN-γ and TNF-α levels were significantly higher in the lesional skin as compared to non-lesional skin (<i>p</i> < 0.05). Furthermore, elevated levels of IFN-γ and TNF-α were observed in patients with active vitiligo (<i>p</i> < 0.05). Additionally, our study suggested a significant increase in granzyme B levels in vitiligo patients (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>Overall, the meta-analysis suggests that IFN-γ, TNF-α and granzyme B play a crucial role in vitiligo pathogenesis and progression and may serve as potential therapeutic targets for managing the disease. The PROSPERO registration no. for meta-analysis is CRD42024620274.</p>\",\"PeriodicalId\":12175,\"journal\":{\"name\":\"Expert Review of Clinical Immunology\",\"volume\":\" \",\"pages\":\"1-14\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-05-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Clinical Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/1744666X.2025.2510491\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/1744666X.2025.2510491","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:白癜风是一种慢性自身免疫性皮肤脱色疾病。IFN-γ、TNF-α和颗粒酶B在白癜风发病中起关键作用,一些研究结果表明它们的作用可能是相互矛盾的。目的:采用荟萃分析方法评估白癜风患者血液和皮肤中IFN-γ、TNF-α和颗粒酶B的水平。此外,我们评估了它们与疾病活动性的关系。方法:采用Review Manager 5.4软件进行meta分析。该研究共纳入55项研究,包括3023名白癜风患者和2534名对照组。结果:我们的荟萃分析结果显示,白癜风患者血液和皮肤中IFN-γ蛋白和转录物水平显著升高(p p p p p p)。结论:总体而言,荟萃分析表明,IFN-γ、TNF-α和颗粒酶B在白癜风的发病和进展中起着至关重要的作用,可能是控制疾病的潜在治疗靶点。普洛斯彼罗注册号:meta分析的编号为CRD42024620274。
Meta-analysis for alterations of IFN-γ, TNF-α and granzyme B levels in vitiligo patients.
Background: Vitiligo is a chronic autoimmune skin depigmenting condition. IFN-γ, TNF-α and granzyme B play key roles in vitiligo pathogenesis, some findings suggest their roles may be contradictory.
Objective: We aimed to assess IFN-γ, TNF-α and granzyme B levels in blood and skin of vitiligo patients using a meta-analysis approach. Additionally, we evaluated their association with disease activity.
Methods: A Meta-analysis was conducted using Review Manager 5.4 software. A total of 55 studies including 3,023 vitiligo patients and 2,534 controls were included in the study.
Results: Pooled results from our meta-analysis indicated significantly elevated IFN-γ protein and transcript levels in blood and skin of vitiligo patients (p < 0.05). TNF-α protein levels were also significantly increased in blood and skin of vitiligo patients (p < 0.05). IFN-γ and TNF-α levels were significantly higher in the lesional skin as compared to non-lesional skin (p < 0.05). Furthermore, elevated levels of IFN-γ and TNF-α were observed in patients with active vitiligo (p < 0.05). Additionally, our study suggested a significant increase in granzyme B levels in vitiligo patients (p < 0.05).
Conclusion: Overall, the meta-analysis suggests that IFN-γ, TNF-α and granzyme B play a crucial role in vitiligo pathogenesis and progression and may serve as potential therapeutic targets for managing the disease. The PROSPERO registration no. for meta-analysis is CRD42024620274.
期刊介绍:
Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.
Articles focus on the following key areas:
• Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines
• Performance and benefits of newly approved therapeutic agents
• New diagnostic approaches
• Screening and patient stratification
• Pharmacoeconomic studies
• New therapeutic indications for existing therapies
• Adverse effects, occurrence and reduction
• Prospects for medicines in late-stage trials approaching regulatory approval
• Novel treatment strategies
• Epidemiological studies
• Commentary and comparison of treatment guidelines
Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.